Cargando…
Antivascular Therapy for Epithelial Ovarian Cancer
Ovarian cancer is the fifth largest cancer killer in women. Improved understanding of the molecular pathways implicated in the pathogenesis of ovarian cancer has led to the investigation of novel targeted therapies. Ovarian cancer is characterized by an imbalance between pro- and antiangiogenic fact...
Autores principales: | Duhoux, Francois P., Machiels, Jean-Pascal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804796/ https://www.ncbi.nlm.nih.gov/pubmed/20072701 http://dx.doi.org/10.1155/2010/372547 |
Ejemplares similares
-
Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer
por: Ma, Xiaocong, et al.
Publicado: (2023) -
Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
HDAC4 Inhibitors as Antivascular Senescence Therapeutics
por: Huang, Chuoji, et al.
Publicado: (2022) -
Use of antivascular endothelial growth factor for diabetic macular edema
por: Karim, Rushmia, et al.
Publicado: (2010)